What are the risks of rapid sodium correction in a patient with Multiple Sclerosis (MS) and hyponatremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Rapid Correction of Sodium Can Cause Osmotic Demyelination Syndrome

Rapid correction of hyponatremia, particularly exceeding 8 mmol/L in 24 hours, can cause osmotic demyelination syndrome (ODS), also known as central pontine myelinolysis (CPM), a devastating neurological complication that can result in permanent disability or death. 1

Critical Correction Rate Limits

The maximum safe correction rate is 8 mmol/L in 24 hours for most patients, with even more cautious rates (4-6 mmol/L per day) required for high-risk populations. 1

  • For severe symptomatic hyponatremia, initial correction should target 6 mmol/L over 6 hours or until symptoms resolve, but total correction must not exceed 8 mmol/L in 24 hours 1
  • Chronic hyponatremia (>48 hours duration) should never be corrected faster than 1 mmol/L per hour 1
  • The rate of correction is more critical than the absolute sodium level achieved 1

High-Risk Populations Requiring Slower Correction

Patients with the following conditions require maximum correction of only 4-6 mmol/L per day: 1

  • Advanced liver disease or cirrhosis 1
  • Chronic alcoholism 1
  • Malnutrition 1
  • Prior encephalopathy 1
  • Hypokalemia, hypophosphatemia, or hypoglycemia 1

These patients have a significantly elevated risk of ODS, with an estimated occurrence of 0.5-1.5% in liver transplant recipients 1

Clinical Presentation of Osmotic Demyelination Syndrome

ODS typically presents with a characteristic biphasic pattern: 1, 2

  • Initial neurological improvement occurs during the first 1-2 days of sodium correction 2
  • Neurological deterioration develops 2-7 days after rapid correction 1, 2
  • Classic symptoms include dysarthria, dysphagia, oculomotor dysfunction (difficulty with eye movements), and quadriparesis 1
  • Eleven of 14 patients who developed complications in one study showed this biphasic course 2

Evidence on Correction Rates and Outcomes

Recent evidence challenges overly restrictive correction rates while confirming the danger of overcorrection: 3

  • Correction rates <6 mmol/L per 24 hours were associated with higher in-hospital mortality compared to 6-10 mmol/L per 24 hours 3
  • Correction rates >10 mmol/L per 24 hours were associated with lower mortality but increased risk of ODS 3
  • In a multicenter study of 3,274 patients with severe hyponatremia, 7 developed CPM, and notably, 5 of these 7 developed CPM despite correction rates ≤8 mmol/L per 24 hours 3
  • Six of 7 patients who developed CPM had alcohol use disorder, malnutrition, hypokalemia, or hypophosphatemia—confirming these as major risk factors 3

Historical data from severe hyponatremia cases demonstrates clear thresholds: 2

  • No neurologic complications occurred when correction was <12 mmol/L per 24 hours 2
  • No complications occurred when correction was <18 mmol/L per 48 hours 2
  • No complications occurred when average correction rate to sodium 120 mmol/L was ≤0.55 mmol/L per hour 2

Special Consideration: Multiple Sclerosis Context

In patients with MS and hyponatremia, the risk of ODS is particularly concerning because: 1, 4

  • MS patients already have demyelinating disease, potentially making them more vulnerable to additional demyelination from ODS 1
  • The neurological symptoms of ODS (dysarthria, dysphagia, motor dysfunction) could be confused with MS exacerbation, delaying recognition 1, 4
  • Cognitive impairment from chronic hyponatremia may compound MS-related cognitive dysfunction 4

Management of Overcorrection

If sodium correction exceeds 8 mmol/L in 24 hours, immediate intervention is required: 1

  • Immediately discontinue current fluids and switch to D5W (5% dextrose in water) to relower sodium levels 1
  • Consider administering desmopressin to slow or reverse the rapid rise in serum sodium 1
  • The goal is to bring total 24-hour correction back to ≤8 mmol/L from the starting point 1

Monitoring Requirements During Correction

Intensive monitoring is essential to prevent overcorrection: 1

  • For severe symptoms: monitor serum sodium every 2 hours during initial correction 1
  • After resolution of severe symptoms: monitor every 4 hours 1
  • Continue frequent monitoring until sodium stabilizes and correction rate is confirmed safe 1

Controversial Evidence on ODS Prevention

Some evidence suggests ODS may occur despite optimal correction rates: 5, 6

  • Three patients corrected at varying rates (slowly with normal saline, quickly with hypertonic saline, or rapidly overcorrected) all developed ODS and died 5
  • One case report documented CPM occurring despite correction rate <8 mmol/L per day, though the patient made a good neurological recovery 6
  • A review of 67 CPM cases found no documented cases in patients treated with water restriction alone or diuretic cessation alone 5
  • This raises the possibility that ODS may sometimes be a complication of severe hyponatremia itself rather than solely its treatment 6

However, the overwhelming consensus from guidelines and larger studies supports the 8 mmol/L per 24-hour limit as protective for most patients. 1, 2, 3

References

Guideline

Management of Sodium Imbalance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective.

Journal of the American Society of Nephrology : JASN, 1994

Guideline

Hyponatremia Symptoms and Complications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Symptomatic hyponatraemia: can myelinolysis be prevented by treatment?

Journal of neurology, neurosurgery, and psychiatry, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.